321 related articles for article (PubMed ID: 31726218)
1. Is rat a good model for assessment of particulate-based taste-masked formulations?
Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P
Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Dissolution Model Can Predict the in Vivo Taste Masking Performance of Coated Multiparticulates.
Keeley A; Teo M; Ali Z; Frost J; Ghimire M; Rajabi-Siahboomi A; Orlu M; Tuleu C
Mol Pharm; 2019 May; 16(5):2095-2105. PubMed ID: 30900905
[TBL] [Abstract][Full Text] [Related]
3. Application of biorelevant saliva-based dissolution for optimisation of orally disintegrating formulations of felodipine.
Ali J; Zgair A; Hameed GS; Garnett MC; Roberts CJ; Burley JC; Gershkovich P
Int J Pharm; 2019 Jan; 555():228-236. PubMed ID: 30465852
[TBL] [Abstract][Full Text] [Related]
4. Development and optimisation of simulated salivary fluid for biorelevant oral cavity dissolution.
Ali J; Bong Lee J; Gittings S; Iachelini A; Bennett J; Cram A; Garnett M; Roberts CJ; Gershkovich P
Eur J Pharm Biopharm; 2021 Mar; 160():125-133. PubMed ID: 33524535
[TBL] [Abstract][Full Text] [Related]
5. Rat Palatability Study for Taste Assessment of Caffeine Citrate Formulation Prepared via Hot-Melt Extrusion Technology.
Tiwari RV; Polk AN; Patil H; Ye X; Pimparade MB; Repka MA
AAPS PharmSciTech; 2017 Feb; 18(2):341-348. PubMed ID: 26573158
[TBL] [Abstract][Full Text] [Related]
6. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of Taste-Masked Donut-Shaped Tablets Via Fused Filament Fabrication 3D Printing Paired with Hot-Melt Extrusion Techniques.
Wang H; Dumpa N; Bandari S; Durig T; Repka MA
AAPS PharmSciTech; 2020 Aug; 21(7):243. PubMed ID: 32856144
[TBL] [Abstract][Full Text] [Related]
8. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
[TBL] [Abstract][Full Text] [Related]
9. Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration.
Lopalco A; Denora N; Laquintana V; Cutrignelli A; Franco M; Robota M; Hauschildt N; Mondelli F; Arduino I; Lopedota A
Int J Pharm; 2020 Jan; 574():118922. PubMed ID: 31836482
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
11. Dissolution methodology for taste masked oral dosage forms.
Gittings S; Turnbull N; Roberts CJ; Gershkovich P
J Control Release; 2014 Jan; 173():32-42. PubMed ID: 24184344
[TBL] [Abstract][Full Text] [Related]
12. Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel.
Münster M; Schoch C; Schmidt C; Breitkreutz J
Eur J Pharm Sci; 2017 Nov; 109():446-454. PubMed ID: 28887230
[TBL] [Abstract][Full Text] [Related]
13. Solid state characterisation and taste masking efficiency evaluation of polymer based extrudates of isoniazid for paediatric administration.
Keating AV; Soto J; Tuleu C; Forbes C; Zhao M; Craig DQM
Int J Pharm; 2018 Feb; 536(2):536-546. PubMed ID: 28687346
[TBL] [Abstract][Full Text] [Related]
14. A review on the taste masking of bitter APIs: hot-melt extrusion (HME) evaluation.
Maniruzzaman M; Boateng JS; Chowdhry BZ; Snowden MJ; Douroumis D
Drug Dev Ind Pharm; 2014 Feb; 40(2):145-56. PubMed ID: 23763436
[TBL] [Abstract][Full Text] [Related]
15. Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs.
Simšič T; Planinšek O; Baumgartner A
Acta Pharm; 2024 Jun; 74(2):177-199. PubMed ID: 38815202
[TBL] [Abstract][Full Text] [Related]
16. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.
Morott JT; Pimparade M; Park JB; Worley CP; Majumdar S; Lian Z; Pinto E; Bi Y; Durig T; Repka MA
J Pharm Sci; 2015 Jan; 104(1):124-34. PubMed ID: 25410968
[TBL] [Abstract][Full Text] [Related]
17. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
Chandrasekaran P; Kandasamy R
AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
[TBL] [Abstract][Full Text] [Related]
18. Design of taste-masked swellable drug particles using dry-coating technology with mechanical curing.
Saeki I; Kondo K; Furukoshi Y; Watanabe Y; Niwa T
Eur J Pharm Biopharm; 2021 Mar; 160():9-22. PubMed ID: 33472100
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.
Shah PP; Mashru RC
AAPS PharmSciTech; 2008; 9(2):494-500. PubMed ID: 18431657
[TBL] [Abstract][Full Text] [Related]
20. Formulation development and in vitro evaluation of fast dispersible, taste masked aceclofenac compacted pellets.
Yasmin R; Shoaib MH; Qazi F; Nasiri MI; Ali T; Ali H; Zafar F
Pak J Pharm Sci; 2019 Jan; 32(1):117-123. PubMed ID: 30772799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
